Marijuana Legalization & Answers to Our “Drug Problem”

Dr. Kelly is the Elizabeth R. Spallin Associate Professor of Psychiatry in Addiction Medicine at Harvard Medical School-the first endowed professor in addiction medicine at Harvard. He is also the founder and Director of the Recovery Research Institute at the Massachusetts General Hospital (MGH), the Program Director of the Addiction Recovery Management Service (ARMS) and the Associate Director of the Center for Addiction Medicine at MGH. Dr. Kelly is a former President of the American Psychological Association (APA) Society of Addiction Psychology, and is also a Fellow of the APA and a diplomate of the American Board of Professional Psychology. He has served as a consultant to U.S. federal agencies and non-Federal institutions, and foreign governments. His clinical and research work has focused on addiction treatment and the recovery process, mechanisms of behavior change, and in reducing stigma and discrimination among individuals suffering from addiction.

Real Options for Legalization

Jonathan Caulkins is the H. Guyford Stever University Professor of Operations Research and Public Policy at Carnegie Mellon University's Heinz College and a member of the National Academy of Engineering.  

Cannabis Legalization & Public Health

Hilary N. Karasz is a Communications Program Manager and Public Information Officer for Public Health – Seattle & King County, where she provides information aimed at improving the health and well-being of the two million residents of King County, Wash.

Cannabis Legalization & Public Health

Beau Kilmer is a Senior Policy Researcher at the RAND Corporation, where he codirects the RAND Drug Policy Research Center and also serves as a professor at the Pardee RAND Graduate School. He has also worked with companies to provide funding for cannabis related businesses.

Regulatory Issues & Marijuana Legislation from a State Perspective

John Carnevale is the President of Carnevale Associates, LLC, a public policy firm that conducts strategic planning, performance measurement and management, research and data analysis and program and policy evaluation for a range of clients in the public and private sectors.

Regulatory Issues & Marijuana Legislation from a State Perspective

Rick Garza has been with the Washington State Liquor and Cannabis Board (WSLCB) since 1997 and currently serves as Deputy Director. During Garza’s career with WSLCB, he has also held the positions of Legislative and Tribal Liaison and Policy Director.

Regulatory Issues & Marijuana Legislation from a State Perspective

Lewis Koski is a co-founder of Freedman & Koski, Inc., a government consulting company focused on implementing marijuana policy using good approaches to government.

The State of the Science of Cannabis

Susan Weiss is the Director, Division of Extramural Research at the National Institute on Drug Abuse (NIDA), which oversees extramural programs, research training activities, operations planning and trans-NIH initiatives, such as the Adolescent Brain Cognitive Development Study.

Let’s Stop Asking, “Should We Legalize Marijuana?”

Andrew Freedman is Co-Founder and Partner of Freedman & Koski, a consulting firm founded by experts with hands-on government experience effectively implementing voter-mandated legalized recreational and medical marijuana while protecting public health, maintaining public safety and keeping marijuana out of the hands of children.